Creative Planning
ARIA

Creative Planning’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Creative Planning’s Portfolio ARIA Stock Details ARIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-26,210
Closed -$326K – 5131
2016
Q4 		$326K Sell
26,210
-990
-4% -$11.9K ﹤0.01% 1153
2016
Q3 		$372K Sell
27,200
-1,800
-6% -$18.1K ﹤0.01% 1057
2016
Q2 		$214K Buy
29,000
+4,500
+18% +$33.8K ﹤0.01% 1229
2016
Q1 		$157K Sell
24,500
-8,300
-25% -$46.5K ﹤0.01% 1347
2015
Q4 		$205K Buy
32,800
+13,500
+70% +$88.6K ﹤0.01% 1187
2015
Q3 		$113K Buy
19,300
+295
+2% +$2.27K ﹤0.01% 1526
2015
Q2 		$157K Buy
19,005
+11,390
+150% +$101K ﹤0.01% 921
2015
Q1 		$63K Sell
7,615
-1,860
-20% -$13.8K ﹤0.01% 1859
2014
Q4 		$65K Sell
9,475
-8,050
-46% -$50.3K ﹤0.01% 1829
2014
Q3 		$95K Buy
17,525
+5,910
+51% +$34.5K ﹤0.01% 1511
2014
Q2 		$74K Buy
11,615
+2,000
+21% +$13.8K ﹤0.01% 1630
2014
Q1 		$77K Buy
9,615
+3,800
+65% +$29.6K ﹤0.01% 1548
2013
Q4 		$40K Sell
5,815
-6,900
-54% -$37.3K ﹤0.01% 1757
2013
Q3 		$234K Buy
12,715
+7,719
+155% +$150K ﹤0.01% 703
2013
Q2 		$87K Buy
+4,996
New +$88.6K ﹤0.01% 1063

Other funds holding ARIA

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Creative Planning's ARIA Position: Q1 2017 in Review

Creative Planning sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 26,210 shares — an estimated $326K sold.

Creative Planning first reported a position in ARIA in Q2 2013 and held it in 15 quarters. The position peaked at $372K in Q3 2016. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

  • Creative Planning reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
  • Creative Planning sold 26,210 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $326K.
  • Creative Planning first reported a position in Ariad Pharmaceuticals Inc in Q2 2013 and held it in 15 quarters.
  • Creative Planning's Ariad Pharmaceuticals Inc position peaked at $372K in Q3 2016.
  • 1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on Creative Planning's 13F filing for Q1 2017, filed 7 Apr 2017.